You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DESYREL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Desyrel, and what generic alternatives are available?

Desyrel is a drug marketed by Pragma and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-two patent family members in twenty-three countries.

The generic ingredient in DESYREL is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desyrel

A generic version of DESYREL was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESYREL?
  • What are the global sales for DESYREL?
  • What is Average Wholesale Price for DESYREL?
Summary for DESYREL
International Patents:32
US Patents:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 134
Clinical Trials: 14
Patent Applications: 1,664
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for DESYREL
What excipients (inactive ingredients) are in DESYREL?DESYREL excipients list
DailyMed Link:DESYREL at DailyMed
Drug patent expirations by year for DESYREL
Drug Sales Revenue Trends for DESYREL

See drug sales revenues for DESYREL

Recent Clinical Trials for DESYREL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 2
National Institute on Aging (NIA)Phase 2
University of Southern CaliforniaPhase 4

See all DESYREL clinical trials

US Patents and Regulatory Information for DESYREL

DESYREL is protected by one US patents.

Patents protecting DESYREL

Trazodone and trazodone hydrochloride in purified form
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pragma DESYREL trazodone hydrochloride TABLET;ORAL 018207-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Pragma DESYREL trazodone hydrochloride TABLET;ORAL 018207-004 Nov 7, 1988 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Pragma DESYREL trazodone hydrochloride TABLET;ORAL 018207-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Pragma DESYREL trazodone hydrochloride TABLET;ORAL 018207-003 Mar 25, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for DESYREL

See the table below for patents covering DESYREL around the world.

Country Patent Number Title Estimated Expiration
Norway 800847 ⤷  Sign Up
European Patent Office 2178850 TRAZODONE ET CHLORHYDRATE DE TRAZODONE SOUS FORME PURIFIÉE (TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM) ⤷  Sign Up
Spain 2517871 ⤷  Sign Up
Poland 2178850 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.